The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
Medical Device Network on MSN
NAMSA acquires Labcorp’s medical device testing assets
The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback